Screener
Zoetis ZTS Income Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $2.47B-0.2% | $2.26B+2.9% | $2.39B+3.0% | $2.4B+0.5% | $2.47B+4.8% | ||
| $673M+1.4% | $641M+3.7% | $712M+0.7% | $683M-2.6% | $664M-0.6% | ||
| $1.8B-0.8% | $1.62B+2.6% | $1.68B+4.0% | $1.72B+1.8% | $1.81B+6.9% | ||
| 72.7%-0.4pp | 71.7%-0.2pp | 70.2%+0.7pp | 71.5%+0.9pp | 73.2%+1.5pp | ||
| $173M+4.2% | $180M+11.1% | $199M+7.0% | $170M+1.8% | $166M-2.9% | ||
| $592M-3.6% | $588M+2.4% | $619M-1.0% | $579M+2.5% | $614M+5.7% | ||
| $61M+15.1% | $62M+14.8% | $57M+11.8% | $58M+1.8% | $53M-10.2% | ||
| $5M+350% | $20M+33.3% | $9M-55.0% | $13M-18.8% | -$2M+92.0% | ||
| $866M-5.0% | $758M-1.9% | $761M+4.0% | $887M+1.5% | $912M+16.9% | ||
| $175M-5.9% | $157M-8.2% | $158M+4.6% | $166M-8.8% | $186M+19.2% | ||
| $691M-4.8% | $601M-0.2% | $603M+3.8% | $721M+5.7% | $726M+16.3% | ||
| 28%-1.3pp | 26.6%-0.8pp | 25.3%+0.2pp | 30%+1.5pp | 29.3%+2.9pp | ||
| $1.65+1.2% | $1.42+6.0% | $1.37+6.2% | $1.63+8.7% | $1.63+19.0% | ||
| $1.05B-3.9% | $939M-0.7% | $939M+3.6% | $1.07B+1.6% | $1.09B+12.7% | ||
| 42.4%-1.6pp | 41.5%-1.5pp | 39.3%+0.2pp | 44.5%+0.5pp | 44%+3.1pp | ||
| $927M-3.9% | $820M-0.8% | $818M+4.5% | $945M+1.5% | $965M+15.0% |
FAQ
- What is Zoetis's revenue?
- Zoetis (ZTS) generated $9.5B in revenue over the trailing twelve months, up 1.5% year over year.
- Is Zoetis profitable?
- Zoetis reported $2.6B in net income over the trailing twelve months, a 27.5% net margin.
- What is Zoetis's earnings per share?
- Zoetis's diluted EPS over the trailing twelve months is $6.07.
- Where does Zoetis's income statement data come from?
- Every line is extracted from Zoetis's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
